Matthew D. Krasowski, MD, PhD, FCAP
Dr. Krasowski is recognized for outstanding leadership as chair of the CAP Toxicology Committee and for his sustained contributions to advancing the specialty of clinical toxicology within laboratory medicine. He is among a small group of pathologists with deep expertise in toxicology and has consistently championed the growth and integration of toxicology testing in clinical laboratories.
Under his leadership, the Toxicology Committee has advanced educational initiatives and supported numerous program studies that resulted in peer‑reviewed publications in the Archives of Pathology & Laboratory Medicine. He recently submitted a proposal for the third edition of CAP Clinical Toxicology Testing: A Guide for Laboratory Professionals, further strengthening educational resources for laboratorians.
Dr. Krasowski is also a co‑author of the Association for Diagnostics & Laboratory Medicine (ADLM) guidance document, “Laboratory Testing for Drug Misuse in the Emergency Department,” which the CAP is in the process of formally endorsing as a practice guideline. His work in this area has contributed to evidence‑based approaches that support appropriate and effective toxicology testing in urgent care settings.
In addition to his contributions in toxicology, Dr. Krasowski is a recognized thought leader in gender‑inclusive laboratory medicine and the provision of care for transgender patients. He has authored numerous peer‑reviewed publications and delivered educational presentations at the CAP annual meeting and other national venues to advance awareness, best practices, and inclusive care within pathology and laboratory medicine.
Dr. Krasowski is a clinical professor of pathology at the University of Iowa Health Care in Iowa City, Iowa.